Stockreport

Conatus' Failure Was A Blow, But The Most Important Study Is Yet To Come [Seeking Alpha]

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations
PDF Recently, Conatus Pharmaceuticals ( CNAT ) reported results from a phase 2b study known as ENCORE-PH. It noted that this study had failed to meet on the primary [Read more]